Highmark medical policy is intended to serve only as a general reference resource regarding coverage for the services described. This policy does not constitute medical advice and is not intended to govern or otherwise influence medical decisions.
This policy provides information regarding the coverage of, as determined by applicable federal and/or state legislation.
This policy is designed to address medical necessity guidelines that are appropriate for the majority of individuals with a particular disease, illness or condition. Each person’s unique clinical circumstances warrant individual consideration, based upon review of applicable medical records.
The qualifications of the policy will meet the standards of the National Committee for Quality Assurance (NCQA) and the Delaware Department of Health and Social Services (DHSS) and all applicable state and federal regulations.
This medical policy outlines Highmark Health Options services for Diagnosis and Treatment of Male Sexual Dysfunction .
Highmark Health Options (HHO) – Managed care organization serving vulnerable populations that have complex needs and qualify for Medicaid. Highmark Health Options members include individuals and families with low income, expecting mothers, children, and people with disabilities. Members pay nothing to very little for their health coverage. Highmark Health Options currently services Delaware Medicaid: Diamond State Health Plan (DSHP), Delaware Healthy Children Program (DHCP), and Diamond State Health Plan Plus (DSHP) LTSS members.
Prior Authorization
Prior Authorization may be required. Please validate codes on the Prior Authorization Lookup Tool https://www.highmarkhealthoptions.com/providers/prior-auth-lookup
Procedures
Erectile dysfunction is defined as the inability to achieve a sufficient erection for satisfactory sexual performance. Erectile function requires competent arterial blood inflow as well as a reduction of venous blood outflow. Disease and other risk factors may affect the arterial and venous systems in a manner that impedes erectile function and may lead to erectile dysfunction.
Please not that Oral and topical pharmacological treatments are not addressed in this policy.
Diagnosis of Male Sexual Dysfunction
The following procedures and tests for the diagnosis of erectile dysfunction may be considered medically necessary:
· Nocturnal Penile Tumescence (NPT) testing
The following diagnostic procedures are considered not medically necessary, as these tests do not have any therapeutic value because spinal cord injury and other neurological deficits that may cause erectile dysfunction are typically identified during a comprehensive history and examination:
· Corpora cavernosal electromyography
· Dorsal nerve conduction latencies
· Evoked potential measurements
Procedures and testing for erectile dysfunction not meeting the criteria as indicated in this policy is considered not medically necessary.
TREATMENT OF MALE SEXUAL DYSFUNCTION
The following treatments may be considered medically necessary for male sexual dysfunction:
Treatment of male sexual dysfunction not meeting the criteria as indicated in this policy is considered not medically necessary.
PENILE PROSTHESES AND EXTERNAL DEVICES
Treatment of male sexual dysfunction with an internal penile prosthesis or an external device may be considered medically necessary when EITHER of the following criteria is met:
The surgical implantation of an internal penile prosthesis may be considered medically necessary when the above criteria have been met.
The removal of an internal penile prosthesis may be considered medically necessary for ANY ONE of the following indications:
Following the removal of an internal penile prosthesis it may be considered medically necessary for surgical re-implantation of an internal penile prosthetic device.
An external device or an internal penile prosthesis insertion or removal not meeting the criteria as indicated in this policy is considered not medically necessary.
PENILE REVASCULARIZATION
Penile revascularization may be considered medically necessary for the treatment of erectile dysfunction when ALL of the following criteria are met:
· The individual presents with erectile dysfunction preceded by blunt perineal or pelvic trauma; and
· The individual has erectile dysfunction that is secondary to a focal arterial occlusion, as evidenced by an arteriogram or duplex ultrasonography conclusive for focal arterial obstruction; and
· There is no evidence of generalized vascular disease (e.g., diabetes mellitus, hypertension, coronary artery disease), Peyronie’s plaques, intracavernosal masses, nodules, or sensory neuropathy; and
· There is evidence of normal corporeal venous function; and
· Alternative nonsurgical treatment modalities have been fully explained to the individual, and the individual is determined to achieve spontaneous erections without the need for pharmacological, external, or internal support devices; and
· The individual is not actively smoking.
Venous ligation performed as a treatment for erectile dysfunction is considered not medically necessary.
Penile revascularization not meeting the criteria as indicated in this policy is considered not medically necessary.
InterQual® Level of Care Criteria, 2021. Acute Care Adult. McKesson Health Solutions, LLC.
Johnsen NV, Kaufman MR, Dmochowski RR & Milam DF. Erectile dysfunction following pelvic fracture urethral injury. Sex Med Rev. 2018;6:114-123.
Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline (2018). 2018. Accessed July 30, 2019.
Kayigil O, Okulu E, Akdemir F, Cakici OU. The combination of penile revascularization surgery with penile corrective techniques as an alternative to prosthesis implantation in patients with peyronie's disease accompanied by erectile dysfunction: Long-term results. Int J Impot Res. 2018;30(2):71-78.
Cosentino M, Bianco M, Ruiz-Castañé E, Iafrate M. Treatment of penile prosthesis implant's infection. Urol Int. 2020;104(7-8):542-545.
Verze P, Sokolakis I, Manfredi C, Collà Ruvolo C, Hatzichristodoulou G, Romero-Otero J. Penile prosthesis implant in the management of Peyronies' disease. Minerva Urol Nephrol. 2021;73(2):196-214.
Cosentino M, Bianco M, Ruiz-Castañé E, Iafrate M. Treatment of penile prosthesis implant's infection. Urol Int. 2020;104(7-8):542-545.
Segal RL, Siegelbaum MH, Lerner BD, Weinberg AC. inflatable penile prosthesis implantation in the ambulatory setting: A systematic review. Sex Med Rev. 2020;8(2):338-347.
Baas W, O'Connor B, Welliver C, et al. Worldwide trends in penile implantation surgery: Data from over 63,000 implants. Transl Androl Urol. 2020;9(1):31-37.
Akdemίr F, Kayıgίl Ö, Algın O, İpek A. The role of computerized tomography angiography in the management of cases undergoing penile revascularization due to erectile dysfunction: Prospective cohort study. BMC Med Imaging. 2022;22(1):217.
Chung E. A review of current and emerging therapeutic options for erectile dysfunction. Med Sci (Basel). 2019;7(9):91.
Ziegelmann MJ, Bajic P, Levine LA. Peyronie's disease: Contemporary evaluation and management. Int J Urol. 2020;27(6):504-516.